Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision tag has been updated to v3.5.4, replacing v3.5.3, signaling a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-05-18T13:52:06.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows an updated “Revision” identifier for the ClinicalTrials.gov interface (v3.5.3 instead of v3.5.2), reflecting a software/content template update rather than a change to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-27T07:33:36.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T02:16:52.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-22T04:36:16.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3. The previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:00:32.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.1 to v3.4.2, which seems to be a minor metadata update with no substantive changes to study design, criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.